New Treatments for Type 2 Diabetes Mellitus and Cardiovascular Disease. The Revolution Has Begun.
Rev Esp Cardiol (Engl Ed) · 2016
Last updated 2026-05-28| Journal | Rev Esp Cardiol (Engl Ed), 2016 |
|---|---|
| Citations | 1 |
| Relative citation ratio | 0.05 |
| NIH percentile | 5 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes, Cardiovascular Risk Reduction |
Full record and abstract on PubMed 27659856 ↗